The identified E2-responsible TRNs provide evidence that ESR1 form modulators with co-TFs or cofactors to regulate the downstream genes, especially with GATA3 to promote E2-inducd gene expression programs in breast cancer. The gene discussed is GATA3; the disease is breast cancer.